GUTS
Price
$1.99
Change
+$0.05 (+2.58%)
Updated
Jun 6 closing price
Capitalization
94.52M
65 days until earnings call
IPSC
Price
$0.62
Change
+$0.06 (+10.71%)
Updated
Jun 6 closing price
Capitalization
48.51M
59 days until earnings call
Interact to see
Advertisement

GUTS vs IPSC

Header iconGUTS vs IPSC Comparison
Open Charts GUTS vs IPSCBanner chart's image
Fractyl Health
Price$1.99
Change+$0.05 (+2.58%)
Volume$406.18K
Capitalization94.52M
Century Therapeutics
Price$0.62
Change+$0.06 (+10.71%)
Volume$3.51M
Capitalization48.51M
GUTS vs IPSC Comparison Chart
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. IPSC commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a StrongBuy and IPSC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (GUTS: $1.90 vs. IPSC: $0.56)
Brand notoriety: GUTS and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 54% vs. IPSC: 49%
Market capitalization -- GUTS: $94.52M vs. IPSC: $48.51M
GUTS [@Biotechnology] is valued at $94.52M. IPSC’s [@Biotechnology] market capitalization is $48.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, GUTS is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 4 TA indicator(s) are bullish while IPSC’s TA Score has 6 bullish TA indicator(s).

  • GUTS’s TA Score: 4 bullish, 4 bearish.
  • IPSC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а +3.26% price change this week, while IPSC (@Biotechnology) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

GUTS is expected to report earnings on Aug 13, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GUTS($94.5M) has a higher market cap than IPSC($48.5M). GUTS YTD gains are higher at: -7.767 vs. IPSC (-44.554). GUTS has higher annual earnings (EBITDA): -92.85M vs. IPSC (-111.47M). IPSC has more cash in the bank: 189M vs. GUTS (67.5M). IPSC has less debt than GUTS: IPSC (53.8M) vs GUTS (62.5M). IPSC has higher revenues than GUTS: IPSC (6.59M) vs GUTS (93K).
GUTSIPSCGUTS / IPSC
Capitalization94.5M48.5M195%
EBITDA-92.85M-111.47M83%
Gain YTD-7.767-44.55417%
P/E RatioN/AN/A-
Revenue93K6.59M1%
Total Cash67.5M189M36%
Total Debt62.5M53.8M116%
TECHNICAL ANALYSIS
Technical Analysis
GUTSIPSC
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 12 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
89%
Aroon
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with YMAB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-2.56%
YMAB - GUTS
35%
Loosely correlated
+4.76%
GLUE - GUTS
34%
Loosely correlated
+1.75%
CGEM - GUTS
34%
Loosely correlated
+0.26%
AKBA - GUTS
33%
Loosely correlated
-1.37%
IPSC - GUTS
33%
Loosely correlated
-0.28%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-0.28%
CRSP - IPSC
55%
Loosely correlated
-0.92%
IMNM - IPSC
51%
Loosely correlated
+0.35%
NTLA - IPSC
49%
Loosely correlated
+3.59%
ABCL - IPSC
49%
Loosely correlated
+3.03%
BEAM - IPSC
48%
Loosely correlated
-0.88%
More